COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,546 Articles (22,881 medRxiv, 8,665 bioRxiv)

Most recent first Previous |  Page 855: Articles 8541-8550  | Next

This is GlycoQL
Hayes, C., Daponte, V., Mariethoz, J., LISACEK, F.
10.1101/2022.04.14.488348 — Posted: 2022-04-14
Mutual inhibition of airway epithelial responses supports viral and fungal co-pathogenesis during coinfection
Dancer, P., Pickard, A., Potocka, W., Earle, K., Fortune-Grant, R., Kadler, K., Bertuzzi, M., Gago, S.
10.1101/2022.04.13.488236 — Posted: 2022-04-14
SARS-CoV-2 Omicron BA.1 variant infection of human colon epithelial cells
Antia, A., Alvarado, D. M., Zeng, Q., Davis, D. L., Ciorba, M. A., Ding, S.
10.1101/2022.04.13.487939 — Posted: 2022-04-14
Epidemiology of infections with SARS-CoV-2 Omicron BA.2 variant in Hong Kong, January-March 2022
Mesfin, Y., Chen, D., Bond, H., Lam, V., Cheung, J., Wong, J., Ali, S. T., Lau, E., Wu, P., Leung, G., Cowling, B. J.
10.1101/2022.04.07.22273595 — Posted: 2022-04-14
Relative infectivity of the SARS-CoV-2 Omicron variant in human alveolar cells
Kim, T., Min, K. I., Yang, J.-S., Kim, J. W., Cho, J., Kim, Y. H., Lee, J. S., Kim, Y. T., Kim, K.-C., Kim, J. Y., Na, K. J., Lee, J.-Y., Ju, Y. S.
10.1101/2022.04.13.486321 — Posted: 2022-04-14
Development of highly specific singleplex and multiplex real-time reverse transcription PCR assays for the identification of SARS-CoV-2 Omicron BA.1, BA.2 and Delta variants
Garson, J. A., Badru, S., Badhan, A., Dustan, S., Tedder, R. S.
10.1101/2022.04.07.22273168 — Posted: 2022-04-14
Determinants of Spike Infectivity, Processing and Neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2
Pastorio, C., Zech, F., Noettger, S., Jung, C., Jacob, T., Sparrer, K. M. J., Kirchhoff, F.
10.1101/2022.04.13.488221 — Posted: 2022-04-14
Epitope Mapping of SARS-CoV-2 Spike Protein Reveals Distinguishable Antibody Binding Activity of Vaccinated and Infected Individuals.
Felbinger, N., Trudil, D. P., Loomis, L. L., Ascione, R., Siragusa, G. R., Haba, S., Mucci, A., Claycomb, M., Snowberger, S., Luke, B., Tsang, S., Francesconi, S. C.
10.1101/2022.04.13.487697 — Posted: 2022-04-14
Level and duration of IgG and neutralizing antibodies to SARS-CoV-2 in children with symptomatic or asymptomatic SARS-CoV-2 infection
Khaitan, A., Datta, D., Bond, C., Goings, M., Co, K., Odhiambo, E. O., Zhang, L., Beasley, S., Poorbaugh, J., John, C. C.
10.1101/2022.04.12.22273466 — Posted: 2022-04-14
Evaluation of machine learning for predicting COVID-19 outcomes from a national electronic medical records database
Lee, S., Browning, S., Belay, E., DeCuir, J., Cato, S. G., Patel, P., Schwartz, N., Wong, K.
10.1101/2022.04.13.22273835 — Posted: 2022-04-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).